Cell-based therapies for Parkinson’s disease

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Expert Review of Neurotherapeutics

• Publication date

  2011-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1586/ern.11.33PMID 21651331
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cell based therapies in Parkinson’s Disease

  2011cited by this paper
• Dopaminergic Neurons Derived from Human Induced Pluripotent Stem Cells Survive and Integrate into 6-OHDA-Lesioned Rats

  2010cited by this paper
• Graft-induced dyskinesias in Parkinson's disease: what is it all about?

  2010cited by this paper
• Direct conversion of fibroblasts to functional neurons by defined factors

  2010cited by this paper
• In Vitro and in Vivo Enhanced Generation of Human A9 Dopamine Neurons from Neural Stem Cells by Bcl-XL*

  2010cited by this paper
• Serotonergic Neurons Mediate Dyskinesia Side Effects in Parkinson’s Patients with Neural Transplants

  2010cited by this paper
• The nonmotor symptoms of Parkinson's disease—An overview

  2010cited by this paper
• Intravenous administration of mesenchymal stem cells exerts therapeutic effects on parkinsonian model of rats: Focusing on neuroprotective effects of stromal cell-derived factor-1α

  2010cited by this paper
• A nonviral minicircle vector for deriving human iPS cells

  2010cited by this paper
• Glial cell line‐derived neurotrophic factor enhances in vitro differentiation of mid‐/hindbrain neural progenitor cells to dopaminergic‐like neurons

  2010cited by this paper
• Dopamine Cell Implantation in Parkinson's Disease: Long-Term Clinical and 18F-FDOPA PET Outcomes

  2010cited by this paper
• Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson's disease.

  2010cited by this paper
• Efficient Generation of Functional Dopaminergic Neurons from Human Induced Pluripotent Stem Cells Under Defined Conditions

  2010cited by this paper
• Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats

  2010cited by this paper
• The A9 dopamine neuron component in grafts of ventral mesencephalon is an important determinant for recovery of motor function in a rat model of Parkinson’s disease

  2010cited by this paper
• Differentiation of non-mesencephalic neural stem cells towards dopaminergic neurons.

  2010cited by this paper
• Identification of transplantable dopamine neuron precursors at different stages of midbrain neurogenesis.

  2009cited by this paper
• Subthalamic nucleus stimulation in Parkinson disease induces apathy

  2009cited by this paper
• Enhanced dopaminergic differentiation of human neural stem cells by synergistic effect of Bcl‐xL and reduced oxygen tension

  2009cited by this paper
• Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins.

  2009cited by this paper
• Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors.

  2009cited by this paper
• piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells

  2009cited by this paper
• 17-P022 Virus-free induction of pluripotency and subsequentexcision of reprogramming factors

  2009cited by this paper
• Induced pluripotent stem cells generated without viral integration

  2009cited by this paper
• Impact of grafted serotonin and dopamine neurons on development of L-DOPA-induced dyskinesias in parkinsonian rats is determined by the extent of dopamine neuron degeneration.

  2008cited by this paper
• Induced Pluripotent Stem Cells Generated Without Viral Integration

  2008cited by this paper
• Functional effect of FGF2- and FGF8-expanded ventral mesencephalic precursor cells in a rat model of Parkinson's disease.

  2008cited by this paper
• Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts

  2008cited by this paper
• Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years

  2008cited by this paper
• Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation

  2008cited by this paper
• Prevalence and correlates of neuropsychiatric symptoms in Parkinson's disease without dementia

  2008cited by this paper
• Induction of A9 dopaminergic neurons from neural stem cells improves motor function in an animal model of Parkinson's disease.

  2008cited by this paper
• Human embryonic stem cell-derived dopaminergic neurons reverse functional deficit in Parkinsonian rats

  2008cited by this paper
• Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease.

  2008cited by this paper
• Wnt5a-treated midbrain neural stem cells improve dopamine cell replacement therapy in parkinsonian mice.

  2008cited by this paper
• Highly efficient and large-scale generation of functional dopamine neurons from human embryonic stem cells

  2008cited by this paper
• Rat mesenchymal stem cells increase tyrosine hydroxylase expression and dopamine content in ventral mesencephalic cells in vitro

  2008cited by this paper
• Disease-specific induced pluripotent stem cells.

  2008cited by this paper
• The black stuff and Konstantin Nikolaevich Tretiakoff

  2008cited by this paper
• Generation of Mouse Induced Pluripotent Stem Cells Without Viral Vectors

  2008cited by this paper
• Efficient derivation of functional dopaminergic neurons from human embryonic stem cells on a large scale

  2008cited by this paper
• Embryonic Stem Cell‐Derived Pitx3‐Enhanced Green Fluorescent Protein Midbrain Dopamine Neurons Survive Enrichment by Fluorescence‐Activated Cell Sorting and Function in an Animal Model of Parkinson's Disease

  2008cited by this paper
• Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease

  2008cited by this paper
• Deep brain stimulation in Parkinson's disease following fetal nigral transplantation

  2008cited by this paper
• A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease.

  2008cited by this paper
• Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease

  2008cited by this paper
• Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells

  2007cited by this paper
• How to make a mesodiencephalic dopaminergic neuron

  2007cited by this paper
• Intrastriatal transplantation of mouse bone marrow-derived stem cells improves motor behavior in a mouse model of Parkinson's disease.

  2007cited by this paper
• Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

  2007cited by this paper
• Stimulation of subterritories of the subthalamic nucleus reveals its role in the integration of the emotional and motor aspects of behavior

  2007cited by this paper
• Human neural progenitor cell transplants into the subthalamic nucleus lead to functional recovery in a rat model of Parkinson's disease.

  2007cited by this paper
• Ngn2 and Nurr1 act in synergy to induce midbrain dopaminergic neurons from expanded neural stem and progenitor cells.

  2007cited by this paper
• Glia-like stem cells sustain physiologic neurogenesis in the adult mammalian carotid body.

  2007cited by this paper
• Carotid body autotransplantation in Parkinson disease: a clinical and positron emission tomography study

  2007cited by this paper
• Neural Precursors Derived from Embryonic Stem Cells, but Not Those from Fetal Ventral Mesencephalon, Maintain the Potential to Differentiate into Dopaminergic Neurons After Expansion In Vitro

  2006cited by this paper
• Development of dopaminergic neurons in the mammalian brain

  2006cited by this paper
• Increased capacity for axonal outgrowth using xenogenic tissue in vitro and in a rodent model of Parkinson's disease

  2006cited by this paper
• Transplantation of Human Embryonic Stem Cell‐Derived Cells to a Rat Model of Parkinson's Disease: Effect of In Vitro Differentiation on Graft Survival and Teratoma Formation

  2006cited by this paper
• Focal not widespread grafts induce novel dyskinetic behavior in parkinsonian rats.

  2006cited by this paper
• Acute oxygen-sensing mechanisms.

  2006cited by this paper
• Deep brain stimulation of the internal segment of the globus pallidus in delayed runaway dyskinesia.

  2006cited by this paper
• The discovery of dopamine deficiency in the parkinsonian brain.

  2006cited by this paper
• Tissue-Specific Stem Cells Neural precursors derived from embryonic stem cells , but not those from fetal ventral mesencephalon , maintain the potential to differentiate into dopaminergic neurons after expansion in vitro

  2006cited by this paper
• Graft placement and uneven pattern of reinnervation in the striatum is important for development of graft-induced dyskinesia.

  2006cited by this paper
• Shedding light into the role of BDNF in the pharmacotherapy of Parkinson's disease

  2006cited by this paper
• Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

  2006cited by this paper
• Murine embryonic stem cell differentiation is promoted by SOCS-3 and inhibited by the zinc finger transcription factor Klf4.

  2005cited by this paper
• Selective Glial Cell Line-Derived Neurotrophic Factor Production in Adult Dopaminergic Carotid Body Cells In Situ and after Intrastriatal Transplantation

  2005cited by this paper
• Purified mouse dopamine neurons thrive and function after transplantation into brain but require novel glial factors for survival in culture.

  2005cited by this paper
• Acute oxygen-sensing mechanisms.

  2005cited by this paper
• Highly efficient endogenous human gene correction using designed zinc-finger nucleases

  2005cited by this paper
• Factors affecting the clinical outcome after neural transplantation in Parkinson's disease.

  2005cited by this paper
• Derivation of midbrain dopamine neurons from human embryonic stem cells.

  2004cited by this paper
• Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation.

  2004cited by this paper
• Adult Bone Marrow Stromal Cells in the Embryonic Brain: Engraftment, Migration, Differentiation, and Long-Term Survival

  2004cited by this paper
• Cognitive Dysfunction in Parkinson’s Disease: The Role of Frontostriatal Circuitry

  2004cited by this paper
• Generation of dopaminergic neurons in vitro from human embryonic stem cells treated with neurotrophic factors.

  2004cited by this paper
• Functional reinnervation of the neostriatum in the adult rat by use of intraparenchymal grafting of dissociated cell suspensions from the substantia nigra

  2004cited by this paper
• Transplantation of Human Embryonic Stem Cell–Derived Neural Progenitors Improves Behavioral Deficit in Parkinsonian Rats

  2004cited by this paper
• Stimulation of STN impairs aspects of cognitive control in PD

  2004cited by this paper
• Neural transplantation for the treatment of Parkinson's disease.

  2003cited by this paper
• Reconstructive neurosurgery for Parkinson's disease: a systematic review and preliminary meta-analysis.

  2003cited by this paper
• Production of alpha 1,3-galactosyltransferase-deficient pigs.

  2003cited by this paper
• GABAergic immunoreactivity is predominant in neurons derived from expanded human neural precursor cells in vitro.

  2003cited by this paper
• A double‐blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease

  2003cited by this paper
• Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease.

  2003cited by this paper
• Multipotent cell lineages in early mouse development depend on SOX2 function.

  2003cited by this paper
• Trophic Restoration of the Nigrostriatal Dopaminergic Pathway in Long-Term Carotid Body-Grafted Parkinsonian Rats

  2003cited by this paper
• Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease

  2002cited by this paper
• Neural transplantation for treatment of Parkinson's disease.

  2002cited by this paper
• Subthalamic DBS replaces levodopa in Parkinson's disease.

  2002cited by this paper
• An essay on the shaking palsy. 1817.

  2002cited by this paper
• Adult bone marrow stromal stem cells express germline, ectodermal, endodermal, and mesodermal genes prior to neurogenesis

  2002cited by this paper
• &agr;Gal is widely expressed in embryonic porcine stem cells and neural tissue

  2002cited by this paper
• Production of α1,3-Galactosyltransferase-Deficient Pigs

  2002cited by this paper
• Dyskinesia after fetal cell transplantation for parkinsonism: A PET study

  2002cited by this paper
• Subthalamic DBS replaces levodopa in Parkinson’s disease: Two-year follow-up

  2002cited by this paper
• Intracerebral transplantation of bone marrow stromal cells in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.

  2001cited by this paper
• Transplantation of embryonic dopamine neurons for severe Parkinson's disease.

  2001cited by this paper

• 6-hydroxydopamine affects multiple pathways to induce cytotoxicity in differentiated LUHMES dopaminergic neurons.

  2023cites this paper
• Association of small intestinal bacterial overgrowth with Parkinson’s disease: a systematic review and meta-analysis

  2021cites this paper
• 22(R)-hydroxycholesterol for dopaminergic neuronal specification of MSCs and amelioration of Parkinsonian symptoms in rats

  2021cites this paper
• Current Therapy and Computational Drug Designing Approaches for Neurodegenerative Diseases -with Focus on Alzheimer’s and Parkinson’s.

  2019cites this paper
• Dopaminergic induction of human dental pulp stem cells by photobiomodulation: comparison of 660nm laser light and polychromatic light in the nir.

  2019cites this paper
• Clinical Cell Therapy Guidelines for Neurorestoration (IANR/CANR 2017)

  2018cites this paper
• Regenerative Medicine in the Digital Age

  2018cites this paper
• Current Experimental Studies of Gene Therapy in Parkinson's Disease

  2017cites this paper
• Integrating Patient Concerns into Parkinson’s Disease Management

  2017cites this paper
• Clinical cell therapy guidelines for neurorestoration (China version 2016)

  2017cites this paper
• Engraftment of Dopamine Neuron Precursor Cells Derived from Adult Mesenchymal Stem Cells: Preliminary In Vivo Study

  2017cites this paper
• Microbiome-Targeted Interventions for Colitis-Associated Bacteria

  2016cites this paper
• An update on potential therapeutic strategies for Parkinson’s disease based on pathogenic mechanisms

  2016cites this paper
• The application of electrospun biofunctional scaffolds for stem cell differentiation and nerve regeneration

  2015cites this paper
• Direct Differentiation of Adult Ocular Progenitors into Striatal Dopaminergic Neurons

  2015cites this paper
• Treating non-motor symptoms of Parkinson’s disease with transplantation of stem cells

  2015cites this paper
• The Development of Treatment for Parkinson's Disease

  2015cites this paper
• Polysaccharide nanofibers with variable compliance for directing cell fate.

  2015cites this paper
• Stem cell therapy: medico-legal perspectives in Italy

  2015cites this paper
• Optimization of surface‐immobilized extracellular matrices for the proliferation of neural progenitor cells derived from induced pluripotent stem cells

  2015cites this paper
• Mash1 efficiently reprograms rat astrocytes into neurons

  2014cites this paper
• Mesenchymal stem cells: potential in treatment of neurodegenerative diseases.

  2014cites this paper
• Neurotransplantation and the Restoration of Motor Behavior in Parkinson’s Disease

  2014cites this paper
• The role of the autophagy-lysosome pathway in in vitro models of neurodegeneration

  2014cites this paper
• Direct Reprogramming of Adult Somatic Cells into other Lineages: Past Evidence and Future Perspectives

  2013cites this paper
• Standard Recommendations for the Application of Chinese Clinical Cell Therapy for Neurorestoration (2012)

  2013cites this paper
• Application of Stem Cells in Ischemic Heart Disease

  2013cites this paper
• The Human Gastrointestinal Tract, a Potential Autologous Neural Stem Cell Source

  2013cites this paper
• Assessment of biological characteristics of adipose tissue-derived stem cells co-labeled with Molday ION Rhodamine B™ and green fluorescent protein in vitro.

  2013cites this paper
• Genetic Correction of Stem Cells in the Treatment of Inherited Diseases and Focus on Xeroderma Pigmentosum

  2013cites this paper
• Mesenchymal stem cells and neuroregeneration in Parkinson's disease.

  2013cites this paper
• Repair of the CNS using endogenous and transplanted neural stem cells.

  2013cites this paper
• Restorative strategies for the dopaminergic nigrostriatal projection pathway.

  2013cites this paper
• Clinical neurotransplantation protocol for Huntington's and Parkinson's disease

  2013cites this paper
• Specimen Collection for Induced Pluripotent Stem Cell Research: Harmonizing the Approach to Informed Consent

  2012cites this paper
• Compositions and methods for treatment of Parkinson's disease: a patent evaluation of WO2011/102847A1

  2012cites this paper
• Genetic strategies to investigate neuronal circuit properties using stem cell-derived neurons

  2012influential citation
• Cell viability and dopamine secretion of 6-hydroxydopamine-treated PC12 cells co-cultured with bone marrow-derived mesenchymal stem cells

  2012cites this paper
• Modeling HIV-associated neurocognitive disorders in mice: new approaches in the changing face of HIV neuropathogenesis

  2012cites this paper
• What is the most promising treatment for Parkinson's disease: genes, cells, growth factors or none of the above?

  2012cites this paper
• Stem Cell Challenges in the Treatment of Neurodegenerative Disease

  2012cites this paper
• A role for interleukin-1β in determining the lineage fate of embryonic rat hippocampal neural precursor cells.

  2012cites this paper
• Transplantation of novel human GDF5-expressing CHO cells is neuroprotective in models of Parkinson's disease

  2012cites this paper
• Ethical Perspectives on Stem Cell-based Cellular Therapies for Neurodegenerative Diseases

  2012influential citation
• Tracing Synaptic Connectivity onto Embryonic Stem Cell‐derived Neurons

  2012cites this paper
• The preclinical discovery of amyotrophic lateral sclerosis drugs

  2011cites this paper
• Labeling of cynomolgus monkey bone marrow-derived mesenchymal stem cells for cell tracking by multimodality imaging

  2011cites this paper
• Brain regeneration in physiology and pathology: the immune signature driving therapeutic plasticity of neural stem cells.

  2011cites this paper
• Transplantation of Neural Stem Cells in Anosmic Mice

  2010cites this paper
• Mesenchymal stem cells for the treatment of neurodegenerative disease.

  2010cites this paper
• Dopaminergic Neurons Derived from Human Induced Pluripotent Stem Cells Survive and Integrate into 6-OHDA-Lesioned Rats

  2010cites this paper
• Stem cells for spinal cord regeneration: Current status

  2010cites this paper
• Digital Commons @ University of South Florida Digital Commons @ University of South Florida

  year unknowncites this paper